Kayne Anderson Rudnick Investment Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.4K | Buy |
149
+15
| +11% | +$3.87K | ﹤0.01% | 624 |
|
|
2025
Q1 | $30K | Sell |
134
-6
| -4% | -$1.34K | ﹤0.01% | 623 |
|
|
2024
Q4 | $32.2K | Buy |
140
+6
| +4% | +$1.38K | ﹤0.01% | 588 |
|
|
2024
Q3 | $32.7K | Hold |
134
| – | – | ﹤0.01% | 583 |
|
|
2024
Q2 | $25.7K | Hold |
134
| – | – | ﹤0.01% | 575 |
|
|
2024
Q1 | $26.5K | Sell |
134
-1
| -0.7% | -$198 | ﹤0.01% | 571 |
|
|
2023
Q4 | $23.2K | Buy |
135
+15
| +13% | +$2.58K | ﹤0.01% | 564 |
|
|
2023
Q3 | $17.7K | Hold |
120
| – | – | ﹤0.01% | 565 |
|
|
2023
Q2 | $26.2K | Hold |
120
| – | – | ﹤0.01% | 543 |
|
|
2023
Q1 | $26.3K | Buy |
120
+1
| +0.8% | +$219 | ﹤0.01% | 530 |
|
|
2022
Q4 | $24.8K | Hold |
119
| – | – | ﹤0.01% | 547 |
|
|
2022
Q3 | $26K | Buy |
+119
| New | +$26K | ﹤0.01% | 515 |
|